NSE filing, NSE: CHANDAN. Summary written from the filing by ALFA Finder's alert engine.
Chandan Healthcare Ltd: key numbers
- Share price
- ₹224.20
- Market cap
- ₹576.2 Cr
- Revenue (annual)
- ₹276.4 Cr
- Net profit (annual)
- ₹28.55 Cr
- P/E (TTM)
- 20.2×Sector 52.0×
- Promoter holding
- 47.20%-2.41% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandan Healthcare Ltd
All →Chandan Healthcare Annual General Meeting
Chandan Healthcare calls an EGM on 20 November 2026 to approve related party transactions, including director guarantees. E-voting runs 17 to 19 November 2026.
Chandan Healthcare Results Update
Chandan Healthcare's Q2 FY2027 revenue from diagnostics grew 46.66% YoY to Rs. 56.38 Crore, while its franchise network expanded to 685 locations.
- franchise expansion
- 410.0 franchises
Chandan Healthcare Debt & Borrowing: ₹5.22 Cr
Chandan Healthcare Limited secured a ₹5.22 Crore medical equipment loan from ICICI Bank for purchasing a 128-slice CT scanner.
- Value
- ₹5.22 Cr
- Execution
- 60 months
Chandan Healthcare Management Change
Mr. Vinod Jain has resigned from his position as Independent Director of Chandan Healthcare Limited, effective October 5, 2026, due to other professional commitments.
Chandan Healthcare Annual General Meeting
Chandan Healthcare Limited held its 23rd Annual General Meeting on September 30, 2026. The meeting covered routine business, including financial adoption and board appointments.
Chandan Healthcare Capital Structure Change
Chandan Healthcare allotted 6,50,000 equity shares upon conversion of warrants for ₹15.21 Crore consideration.
- Value
- ₹15.21 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.